| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6908053
[patent_doc_number] => 20010010820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-02
[patent_title] => 'TARGETING OF PEG ANTIBODY CONJUGATES TO ISLET CELLS'
[patent_app_type] => new
[patent_app_number] => 09/222357
[patent_app_country] => US
[patent_app_date] => 1998-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9074
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20010010820.pdf
[firstpage_image] =>[orig_patent_app_number] => 09222357
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/222357 | TARGETING OF PEG ANTIBODY CONJUGATES TO ISLET CELLS | Dec 28, 1998 | Abandoned |
| 09/215848 | NOVEL HUMAN MAGE-LIKE PROTEIN | Dec 17, 1998 | Abandoned |
Array
(
[id] => 4213693
[patent_doc_number] => 06087125
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Polynucleotide encoding a novel human nm23-like protein'
[patent_app_type] => 1
[patent_app_number] => 9/199842
[patent_app_country] => US
[patent_app_date] => 1998-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18118
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/087/06087125.pdf
[firstpage_image] =>[orig_patent_app_number] => 199842
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/199842 | Polynucleotide encoding a novel human nm23-like protein | Nov 23, 1998 | Issued |
| 09/068586 | DIAGNOSIS OF DISEASE STATE USING MRNA PROFILES | Oct 25, 1998 | Abandoned |
Array
(
[id] => 1542062
[patent_doc_number] => 06372439
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-04-16
[patent_title] => 'Screen for gastric adenocarcinoma'
[patent_app_type] => B2
[patent_app_number] => 09/164954
[patent_app_country] => US
[patent_app_date] => 1998-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4224
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/372/06372439.pdf
[firstpage_image] =>[orig_patent_app_number] => 09164954
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/164954 | Screen for gastric adenocarcinoma | Sep 30, 1998 | Issued |
Array
(
[id] => 472161
[patent_doc_number] => 07229770
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-06-12
[patent_title] => 'YKL-40 as a marker and prognostic indicator for cancers'
[patent_app_type] => utility
[patent_app_number] => 09/164862
[patent_app_country] => US
[patent_app_date] => 1998-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 32846
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/229/07229770.pdf
[firstpage_image] =>[orig_patent_app_number] => 09164862
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/164862 | YKL-40 as a marker and prognostic indicator for cancers | Sep 30, 1998 | Issued |
Array
(
[id] => 1037662
[patent_doc_number] => 06872811
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-29
[patent_title] => 'HRPCa9 and HRPCa10 nucleic acids and polypeptides'
[patent_app_type] => utility
[patent_app_number] => 09/163759
[patent_app_country] => US
[patent_app_date] => 1998-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 25854
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872811.pdf
[firstpage_image] =>[orig_patent_app_number] => 09163759
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/163759 | HRPCa9 and HRPCa10 nucleic acids and polypeptides | Sep 29, 1998 | Issued |
Array
(
[id] => 1365209
[patent_doc_number] => 06566072
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Mammaglobin, a secreted mammary-specific breast cancer protein'
[patent_app_type] => B1
[patent_app_number] => 09/162622
[patent_app_country] => US
[patent_app_date] => 1998-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 15700
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566072.pdf
[firstpage_image] =>[orig_patent_app_number] => 09162622
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/162622 | Mammaglobin, a secreted mammary-specific breast cancer protein | Sep 28, 1998 | Issued |
| 09/159027 | BIFUNCTIONAL PROTEIN, PREPARATION AN USE | Sep 22, 1998 | Abandoned |
| 09/157247 | ASTHMA ASSOCIATED FACTORS AS TARGETS FOR TREATING ATOPIC ALLERGIES INCLUDING ASTHAMA AND RELATED DISORDERS | Sep 17, 1998 | Abandoned |
Array
(
[id] => 5968010
[patent_doc_number] => 20020090642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'METHODS FOR DETERMINING THE PROGNOSIS OF BREAST CANCER USING ANTIBODIES SPECIFIC FOR THYMIDYLATE SYNTHASE'
[patent_app_type] => new
[patent_app_number] => 09/152647
[patent_app_country] => US
[patent_app_date] => 1998-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5887
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20020090642.pdf
[firstpage_image] =>[orig_patent_app_number] => 09152647
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/152647 | METHODS FOR DETERMINING THE PROGNOSIS OF BREAST CANCER USING ANTIBODIES SPECIFIC FOR THYMIDYLATE SYNTHASE | Sep 13, 1998 | Abandoned |
| 09/136522 | ANTITUMOR AGENTS | Aug 18, 1998 | Abandoned |
Array
(
[id] => 4180633
[patent_doc_number] => 06150117
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Method for diagnosis of cancer'
[patent_app_type] => 1
[patent_app_number] => 9/135599
[patent_app_country] => US
[patent_app_date] => 1998-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 6900
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/150/06150117.pdf
[firstpage_image] =>[orig_patent_app_number] => 135599
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/135599 | Method for diagnosis of cancer | Aug 17, 1998 | Issued |
Array
(
[id] => 4333203
[patent_doc_number] => 06333028
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Method of using haptenized ovarian carcinoma tumor cells'
[patent_app_type] => 1
[patent_app_number] => 9/134465
[patent_app_country] => US
[patent_app_date] => 1998-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18279
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333028.pdf
[firstpage_image] =>[orig_patent_app_number] => 134465
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/134465 | Method of using haptenized ovarian carcinoma tumor cells | Aug 13, 1998 | Issued |
| 09/125005 | PURIFIED SR-P70 PROTEIN | Jul 29, 1998 | Abandoned |
Array
(
[id] => 1092459
[patent_doc_number] => 06824971
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-30
[patent_title] => 'Methods of inhibiting or enhancing the TGF-SMAD signaling pathway'
[patent_app_type] => B1
[patent_app_number] => 09/107779
[patent_app_country] => US
[patent_app_date] => 1998-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 67
[patent_no_of_words] => 28618
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/824/06824971.pdf
[firstpage_image] =>[orig_patent_app_number] => 09107779
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/107779 | Methods of inhibiting or enhancing the TGF-SMAD signaling pathway | Jun 29, 1998 | Issued |
| 09/106920 | MOLECULES ASSOCIATED WITH APOPTOSIS | Jun 28, 1998 | Abandoned |
Array
(
[id] => 4159981
[patent_doc_number] => 06156882
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-05
[patent_title] => 'Antibody 4G8B4B12'
[patent_app_type] => 1
[patent_app_number] => 9/105596
[patent_app_country] => US
[patent_app_date] => 1998-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 3286
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/156/06156882.pdf
[firstpage_image] =>[orig_patent_app_number] => 105596
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/105596 | Antibody 4G8B4B12 | Jun 25, 1998 | Issued |
Array
(
[id] => 4362594
[patent_doc_number] => 06255457
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-03
[patent_title] => 'Tissue-specific monoclonal antibodies'
[patent_app_type] => 1
[patent_app_number] => 9/029459
[patent_app_country] => US
[patent_app_date] => 1998-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15031
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/255/06255457.pdf
[firstpage_image] =>[orig_patent_app_number] => 029459
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/029459 | Tissue-specific monoclonal antibodies | Jun 24, 1998 | Issued |
Array
(
[id] => 1536710
[patent_doc_number] => 06337387
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-08
[patent_title] => 'Differentiation-suppressive polypeptide'
[patent_app_type] => B1
[patent_app_number] => 09/068740
[patent_app_country] => US
[patent_app_date] => 1998-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 32543
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/337/06337387.pdf
[firstpage_image] =>[orig_patent_app_number] => 09068740
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/068740 | Differentiation-suppressive polypeptide | Jun 17, 1998 | Issued |